ATI CONTENT MASTERY
PHARMACOLOGY
PRACTICE TEST 1
───────────────────────────────────────────────────────
40 Questions | Actual Latest Questions & 100% Verified Answers | Graded A+
Assessment Technologies Institute (ATI) Nursing Education
Comprehensive Pharmacological Competency Assessment
ATI/NGN-Aligned Format
NCSBN Clinical Judgment Measurement Model (CJMM)
Based on ATI Pharmacology Content Mastery Modules, NCSBN NCLEX-RN Test Plan (2023-
2026), standard pharmacology textbooks (Lehne, Rosenthal & Burchum), and clinical practice
guidelines.
, EXAM STRUCTURE & INTRODUCTION
This ATI Content Mastery Pharmacology Practice Test 1 format for 2026/2027 reflects the
standardized competency assessment administered by Assessment Technologies Institute (ATI) to
evaluate proficiency in pharmacological principles for pre-licensure nursing students. The exam
measures knowledge of pharmacokinetic/pharmacodynamic concepts, medication administration
safety, system-specific drug classes (cardiovascular, respiratory, endocrine, CNS, pain, infectious
disease, GI), obstetric/pediatric considerations, drug interaction recognition, adverse effect
monitoring, patient education strategies, and scenario-based clinical decision-making using Next
Generation NCLEX-aligned item types. The standard ATI Content Mastery Pharmacology Practice
Test consists of approximately 40 multiple-choice and NGN-style questions covering these critical
pharmacology domains, designed to reinforce evidence-based medication management practice
and NCLEX-RN readiness.
Total Questions: 40 multiple-choice and Next Generation NCLEX-style questions
Question Types: Single-best-answer, SATA, Bowtie, Trend, Highlight, Matrix, Ordered Response,
and Scenario-based items
Testing Time: Approximately 60-90 minutes (computer-based, proctored format)
Passing Score: Institution-specific benchmark (typically 75-85% equivalent or ATI scaled score
threshold)
Focus: Evidence-based pharmacotherapeutic principles, medication safety, NCSBN CJMM and
NGN standards
, Question 1 [Multiple Choice]
Domain: Pharmacokinetics & Pharmacodynamics
A nurse is reviewing the mechanism of action of a newly prescribed medication with
a patient. The nurse explains that the medication undergoes extensive first-pass
metabolism. Which statement by the patient indicates an understanding of this
concept?
A. "The medication will be most effective when taken with a high-fat meal to increase
absorption."
B. "The medication may lose a significant amount of its active form before
reaching systemic circulation when taken orally."
C. "The medication will be excreted unchanged by the kidneys, so I need to drink plenty of
water."
D. "The medication will bind strongly to plasma proteins and may cause drug interactions."
Correct Answer: B. "The medication may lose a significant amount of its active form
before reaching systemic circulation when taken orally."
Rationale: First-pass metabolism refers to the hepatic inactivation of orally administered drugs
before they enter systemic circulation. Drugs with high first-pass effect may require higher oral
doses or alternative routes (e.g., sublingual, IV) to achieve therapeutic effects. This is a
fundamental pharmacokinetic principle essential for NCLEX-RN preparation (Lehne,
Pharmacology for Nursing Care, 10th ed.).
──────────────────────────────────────────────────────────────
──────────────────
Question 2 [Select All That Apply (SATA)]
Domain: Pharmacokinetics & Pharmacodynamics
A nurse is caring for a patient receiving a drug with a narrow therapeutic index.
Which of the following medications are classified as having a narrow therapeutic
index? (Select all that apply.)
A. Warfarin
B. Lithium
C. Phenytoin
D. Ibuprofen
E. Digoxin
F. Acetaminophen
Correct Answer: A. Warfarin; B. Lithium; C. Phenytoin; E. Digoxin
Rationale: Warfarin, lithium, phenytoin, and digoxin all have narrow therapeutic indices,
meaning the difference between a therapeutic and toxic dose is small. These medications require
frequent serum drug level monitoring, dose adjustments, and careful patient education.
Ibuprofen and acetaminophen have wider therapeutic windows and are safer for general use.
Narrow therapeutic index drugs are designated high-alert medications by ISMP.
PHARMACOLOGY
PRACTICE TEST 1
───────────────────────────────────────────────────────
40 Questions | Actual Latest Questions & 100% Verified Answers | Graded A+
Assessment Technologies Institute (ATI) Nursing Education
Comprehensive Pharmacological Competency Assessment
ATI/NGN-Aligned Format
NCSBN Clinical Judgment Measurement Model (CJMM)
Based on ATI Pharmacology Content Mastery Modules, NCSBN NCLEX-RN Test Plan (2023-
2026), standard pharmacology textbooks (Lehne, Rosenthal & Burchum), and clinical practice
guidelines.
, EXAM STRUCTURE & INTRODUCTION
This ATI Content Mastery Pharmacology Practice Test 1 format for 2026/2027 reflects the
standardized competency assessment administered by Assessment Technologies Institute (ATI) to
evaluate proficiency in pharmacological principles for pre-licensure nursing students. The exam
measures knowledge of pharmacokinetic/pharmacodynamic concepts, medication administration
safety, system-specific drug classes (cardiovascular, respiratory, endocrine, CNS, pain, infectious
disease, GI), obstetric/pediatric considerations, drug interaction recognition, adverse effect
monitoring, patient education strategies, and scenario-based clinical decision-making using Next
Generation NCLEX-aligned item types. The standard ATI Content Mastery Pharmacology Practice
Test consists of approximately 40 multiple-choice and NGN-style questions covering these critical
pharmacology domains, designed to reinforce evidence-based medication management practice
and NCLEX-RN readiness.
Total Questions: 40 multiple-choice and Next Generation NCLEX-style questions
Question Types: Single-best-answer, SATA, Bowtie, Trend, Highlight, Matrix, Ordered Response,
and Scenario-based items
Testing Time: Approximately 60-90 minutes (computer-based, proctored format)
Passing Score: Institution-specific benchmark (typically 75-85% equivalent or ATI scaled score
threshold)
Focus: Evidence-based pharmacotherapeutic principles, medication safety, NCSBN CJMM and
NGN standards
, Question 1 [Multiple Choice]
Domain: Pharmacokinetics & Pharmacodynamics
A nurse is reviewing the mechanism of action of a newly prescribed medication with
a patient. The nurse explains that the medication undergoes extensive first-pass
metabolism. Which statement by the patient indicates an understanding of this
concept?
A. "The medication will be most effective when taken with a high-fat meal to increase
absorption."
B. "The medication may lose a significant amount of its active form before
reaching systemic circulation when taken orally."
C. "The medication will be excreted unchanged by the kidneys, so I need to drink plenty of
water."
D. "The medication will bind strongly to plasma proteins and may cause drug interactions."
Correct Answer: B. "The medication may lose a significant amount of its active form
before reaching systemic circulation when taken orally."
Rationale: First-pass metabolism refers to the hepatic inactivation of orally administered drugs
before they enter systemic circulation. Drugs with high first-pass effect may require higher oral
doses or alternative routes (e.g., sublingual, IV) to achieve therapeutic effects. This is a
fundamental pharmacokinetic principle essential for NCLEX-RN preparation (Lehne,
Pharmacology for Nursing Care, 10th ed.).
──────────────────────────────────────────────────────────────
──────────────────
Question 2 [Select All That Apply (SATA)]
Domain: Pharmacokinetics & Pharmacodynamics
A nurse is caring for a patient receiving a drug with a narrow therapeutic index.
Which of the following medications are classified as having a narrow therapeutic
index? (Select all that apply.)
A. Warfarin
B. Lithium
C. Phenytoin
D. Ibuprofen
E. Digoxin
F. Acetaminophen
Correct Answer: A. Warfarin; B. Lithium; C. Phenytoin; E. Digoxin
Rationale: Warfarin, lithium, phenytoin, and digoxin all have narrow therapeutic indices,
meaning the difference between a therapeutic and toxic dose is small. These medications require
frequent serum drug level monitoring, dose adjustments, and careful patient education.
Ibuprofen and acetaminophen have wider therapeutic windows and are safer for general use.
Narrow therapeutic index drugs are designated high-alert medications by ISMP.
